Study guide

Low-vision assessment and magnification

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Low-vision assessment and magnification

Key Takeaways Explain This Topic AI

Rehabilitation starts with the patient’s functional goals and assessment of remaining vision and treatable disease.

Relative-size, relative-distance, angular and electronic magnification offer different practical tradeoffs.

A distance-acuity rule provides only a starting estimate; near-reading performance determines the final aid.

Last updated: October 2026

Note

Low vision rehabilitation addresses irreversible visual impairment resulting from macular pathology, diabetic retinopathy, advanced glaucoma, and hereditary optic neuropathies. EBOD candidates must understand residual visual assessment, optical magnification formulas, telescopic ray vergence, and environmental modifications.

Visual impairment and functional assessment

WHO distance-impairment categories use presenting distance acuity in the better eye : mild impairment is worse than 6/12 to at least 6/18; moderate is worse than 6/18 to at least 6/60; severe is worse than 6/60 to at least 3/60; blindness is worse than 3/60. Near impairment is presenting near acuity worse than N6 or M0.8 at 40 cm. These population categories should not be conflated with every country's legal certification criteria.

  • Measurement What it contributes
  • Presenting acuity Function with the correction currently used
  • Best-corrected acuity Potential improvement with refraction
  • Visual field Peripheral or central loss not captured by acuity alone
  • Contrast, glare and reading performance Difficulties under realistic task conditions

Rehabilitation is based on the patient's goals, not solely a numerical category. Determine whether the priority is reading medication labels, sustained text, mobility, recognising faces or a work task. Evaluate refraction and treatable pathology, then assess near performance and an appropriate aid. Certification and rehabilitation can be relevant even when acuity alone understates field loss.

Source: WHO vision impairment fact sheet .

Assessment of Residual Visual Function

Standard clinical Snellen testing is inadequate in low vision due to unequal letter counts per line, variable letter difficulty, irregular progression ratios, and non-standardized letter crowding.

1. The LogMAR (ETDRS) Protocol

The Early Treatment Diabetic Retinopathy Study (ETDRS) LogMAR chart overcomes these limitations:

Logarithmic Step Size: Line progression follows a constant geometric progression ratio of 0.1 LogMAR 0.1\text{ LogMAR} 0.1 LogMAR ( 10 0.1 ≈ 1.2589 × 10^{0.1} \approx 1.2589\times 1 0 0.1 ≈ 1.2589 × change in letter height per line).

Standardized Letter Allocation: Exactly 5 Sloan letters per line; each letter read correctly confers 0.02 LogMAR 0.02\text{ LogMAR} 0.02 LogMAR credit.

Proportional Spacing: Inter-letter spacing equals the width of one letter on that line; inter-line spacing equals the height of the lower line.

Testing Distance Flexibility: Standard testing is conducted at 4 m 4\text{ m} 4 m ; in low vision, testing moves to 2 m 2\text{ m} 2 m (add + 0.30 LogMAR +0.30\text{ LogMAR} + 0.30 LogMAR ) or 1 m 1\text{ m} 1 m (add + 0.60 LogMAR +0.60\text{ LogMAR} + 0.60 LogMAR ) to prevent ceiling/floor truncation.

Distance Snellen ( 6 m 6\text{ m} 6 m ) Distance Snellen ( 20 ft 20\text{ ft} 20 ft ) Decimal Acuity LogMAR Acuity Letter Count Score (ETDRS)

6 / 6 6/6 6/6 20 / 20 20/20 20/20 1.00 1.00 1.00 0.00 0.00 0.00 85 letters 85\text{ letters} 85 letters

6 / 12 6/12 6/12 20 / 40 20/40 20/40 0.50 0.50 0.50 + 0.30 +0.30 + 0.30 70 letters 70\text{ letters} 70 letters

6 / 18 6/18 6/18 20 / 60 20/60 20/60 0.33 0.33 0.33 + 0.48 +0.48 + 0.48 61 letters 61\text{ letters} 61 letters

6 / 30 6/30 6/30 20 / 100 20/100 20/100 0.20 0.20 0.20 + 0.70 +0.70 + 0.70 50 letters 50\text{ letters} 50 letters

6 / 60 6/60 6/60 20 / 200 20/200 20/200 0.10 0.10 0.10 + 1.00 +1.00 + 1.00 35 letters 35\text{ letters} 35 letters

3 / 60 3/60 3/60 20 / 400 20/400 20/400 0.05 0.05 0.05 + 1.30 +1.30 + 1.30 20 letters 20\text{ letters} 20 letters

2. Contrast Sensitivity: The Pelli-Robson Chart

High-contrast acuity measures only the high spatial frequency limit of vision. Patients with age-related macular degeneration or glaucoma often complain of severe visual disability despite near-normal high-contrast acuity ( 6 / 12 6/12 6/12 ).

The Pelli-Robson chart presents triplets of Sloan letters of uniform large size ( 4.9 × 4.9 cm 4.9 \times 4.9\text{ cm} 4.9 × 4.9 cm , subtending 2.8 ∘ 2.8^\circ 2. 8 ∘ at 1 m 1\text{ m} 1 m , isolating low-to-intermediate spatial frequencies of ≈ 1 cycle/degree \approx 1\text{ cycle/degree} ≈ 1 cycle/degree ).

Contrast declines across triplets in steps of 0.15 log units 0.15\text{ log units} 0.15 log units .

Normal adult contrast sensitivity is ≥ 1.65 − 1.95 log units \ge 1.65 - 1.95\text{ log units} ≥ 1.65 − 1.95 log units . A score < 1.50 log units \lt 1.50\text{ log units} < 1.50 log units correlates with reading fatigue, impaired facial recognition, and elevated fall risk.

3. Near Vision Acuity & M-Units

Near acuity can be recorded in M-units , noting distance and chart; Jaeger labels are poorly standardised:

1.0 M 1.0\text{M} 1.0 M Letter Height: Subtends 5 minutes of arc 5\text{ minutes of arc} 5 minutes of arc at a distance of 1 meter 1\text{ meter} 1 meter ( 1.454 mm 1.454\text{ mm} 1.454 mm capital letter height), equivalent to standard 8 -point 8\text{-point} 8 -point newsprint.

Snellen Near Fraction: Recorded as testing distance (meters) over M-size (e.g., 0.4 / 1.0 M = 20 / 50 0.4 / 1.0\text{M} = 20/50 0.4/1.0 M = 20/50 Snellen equivalent at 40 cm 40\text{ cm} 40 cm ).

Principles & Forms of Magnification

Magnification increases the angle subtended by the retinal image, stimulating healthy extra-foveal parafoveal photoreceptors.

The Four Fundamental Mechanisms

Relative Size Magnification ( M S M_S M S ​ ): The physical size of the object is increased while the viewing distance remains constant: M S = New Object Size Original Object Size M_S = \frac{\text{New Object Size}}{\text{Original Object Size}} M S ​ = Original Object Size New Object Size ​ Examples: Large-print books, 24 -point 24\text{-point} 24 -point display fonts, jumbo keyboards.

Relative Distance Magnification ( M D M_D M D ​ ): The object is moved closer to the eye without altering its physical dimensions: M D = Original Working Distance New Working Distance M_D = \frac{\text{Original Working Distance}}{\text{New Working Distance}} M D ​ = New Working Distance Original Working Distance ​ Example: Moving a reading card from 40 cm 40\text{ cm} 40 cm to 10 cm 10\text{ cm} 10 cm yields M D = 40 / 10 = 4 × M_D = 40 / 10 = 4\times M D ​ = 40/10 = 4 × magnification.

Angular Magnification ( M A M_A M A ​ ): An afocal optical instrument (telescope) enlarges the visual angle subtended at the eye without changing physical distance or size: M A = tan ⁡ θ ′ tan ⁡ θ = − F eyepiece F objective M_A = \frac{\tan \theta'}{\tan \theta} = -\frac{F_{\text{eyepiece}}}{F_{\text{objective}}} M A ​ = t a n θ t a n θ ′ ​ = − F objective ​ F eyepiece ​ ​

Electronic (Electro-Optical) Magnification ( M E M_E M E ​ ): Closed-circuit television (CCTV) systems and portable digital magnifiers combine relative size magnification and electronic sensor processing, providing 2 × 2\times 2 × to 60 × 60\times 60 × magnification with adjustable contrast polarity (e.g., white letters on black background to reduce intraocular glare).